| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Fibrosis | |||||
| Focal Glomerulosclerosis | |||||
| Kidney Failure | |||||
| Nephrotic Syndrome | |||||
| Proteinuria | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Glomerulosclerosis, Focal Segmental | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Disease | |||||
| Glomerulonephritis | |||||
| Kidney Diseases | |||||
| Nephritis | |||||
| Nephrosis | |||||
| Pathologic Processes | |||||
| Renal Insufficiency | |||||
| Signs and Symptoms | |||||
| Urination Disorders | |||||
| Urologic Diseases | |||||
| Urological Manifestations | |||||
| 4 | Interventions listed in this trial | ||||
| Pirfenidone | |||||
| 5 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Non-Narcotic | |||||
| Anti-Inflammatory Agents | |||||
| Anti-Inflammatory Agents, Non-Steroidal | |||||
| Antineoplastic Agents | |||||
| Antirheumatic Agents | |||||
| Central Nervous System Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
|
